Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nathan C. Skorodin
16  Ergebnisse:
Personensuche X
?
1

Tocilizumab as a Therapeutic Agent for Critically Ill Patie..:

Petrak, Russell M. ; Skorodin, Nathan C. ; Van Hise, Nicholas W....
Clinical and Translational Science.  14 (2021)  6 - p. 2146-2151 , 2021
Link: https://doi.org/10.1111/..
 
?
2

Early Tocilizumab Dosing Is Associated With Improved Surviv..:

Petrak, Russell M. ; Van Hise, Nicholas W. ; Skorodin, Nathan C....
Critical Care Explorations.  3 (2021)  4 - p. e0395 , 2021
Link: https://doi.org/10.1097/..
 
?
3

A Real-World Assessment of Clinical Outcomes and Safety of ..:

Van Hise, Nicholas ; Petrak, Russell M. ; Skorodin, Nathan C....
Infectious Diseases and Therapy.  9 (2020)  4 - p. 1017-1028 , 2020
Link: https://doi.org/10.1007/..
 
?
4

Value and Clinical Impact of an Infectious Disease-Supervis..:

Petrak, Russell M. ; Skorodin, Nathan C. ; Fliegelman, Robert M....
Open Forum Infectious Diseases.  3 (2016)  4 - p. , 2016
Link: https://doi.org/10.1093/..
 
?
5

Early Tocilizumab Dosing Is Associated With Improved Surviv..:

Russell M. Petrak, MD ; Nicholas W. Van Hise, PharmD ; Nathan C. Skorodin, PharmD...
http://journals.lww.com/10.1097/CCE.0000000000000395.  , 2021
Link: https://doi.org/10.1097/..
 
?
6

Tocilizumab as a Therapeutic Agent for Critically Ill Patie..:

Petrak, Russell M ; Skorodin, Nathan C ; Van Hise, Nicholas W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604239/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Early Tocilizumab Dosing Is Associated With Improved Surviv..:

Petrak, Russell M ; Van Hise, Nicholas W ; Skorodin, Nathan C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009634/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Tocilizumab as a Therapeutic Agent for Critically Ill Patie..:

Russell M. Petrak ; Nathan C. Skorodin ; Nicholas W. Van Hise...
https://doi.org/10.1111/cts.12894.  , 2021
Link: https://doi.org/10.1111/..
 
?
9

A Real-World Assessment of Clinical Outcomes and Safety of ..:

Van Hise, Nicholas ; Petrak, Russell M ; Skorodin, Nathan C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680490/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

A Real-World Assessment of Clinical Outcomes and Safety of ..:

Nicholas Van Hise ; Russell M. Petrak ; Nathan C. Skorodin...
https://doi.org/10.1007/s40121-020-00351-0.  , 2020
Link: https://doi.org/10.1007/..
 
?
11

Value and Clinical Impact of an Infectious Disease-Supervis..:

Petrak, Russell M ; Skorodin, Nathan C ; Fliegelman, Robert M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088696/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
12

Review of Treatment Failures in an ID-Supervised Outpatient..:

Skorodin, Nathan ; Petrak, Russell ; Hines, David W..
Open Forum Infectious Diseases.  2 (2015)  suppl_1 - p. , 2015
Link: https://doi.org/10.1093/..
 
?
13

Clinical Effectiveness of an ID Supervised Outpatient Paren..:

Skorodin, Nathan ; Petrak, Russell ; Fliegelman, Robert.
Open Forum Infectious Diseases.  2 (2015)  suppl_1 - p. , 2015
Link: https://doi.org/10.1093/..
 
?
14

740Hospital Avoidance Utilizing an ID Supervised OPAT Progr..:

Skorodin, Nathan ; Petrak, Russell ; Hines, David W..
Open Forum Infectious Diseases.  1 (2014)  suppl_1 - p. S209-S209 , 2014
Link: https://doi.org/10.1093/..
 
?
15

BLOOD CHEMICAL CHANGES OCCURRING IN THE TREATMENT OF PSYCHO..:

Maurer, S. ; Wiles, H. O. ; Marberg, C. M...
American Journal of Psychiatry.  94 (1938)  6 - p. 1355-1362 , 1938
Link: https://doi.org/10.1176/..
 
1-15